The African Medicines Agency - A potential gamechanger that requires strategic focus

Affiliations

¹ Vaccines for All, Pune, India.
² African Medicines Agency Secretariat, Kigali, Rwanda.
³ International Vaccine Institute, Kigali, Rwanda.
⁴ African Medicines Harmonization Initiative, AUDA NEPAD, South Africa.
⁵ Egyptian Drug Authority (EDA), Agouza, Giza, Egypt.
⁶ NAFDAC, Zone 7, Abuja, Nigeria.
⁷ Ghana Food and Drugs Authority, Accra, Ghana.
⁸ Food and Drugs Authority, Tanzania.
⁹ Medicines Control Authority of Zimbabwe, Harare, Zimbabwe.
¹⁰ South African Health Products Regulatory Authority, Pretoria, South Africa.
¹¹ Rwanda Food and Drugs Authority, Kigali, Rwanda.
¹² African Medicines Agency, Kigali, Rwanda.
¹³ College of Natural Sciences, Seoul National University, Seoul, South Korea.
¹⁴ Africa Centres for Disease Control and Prevention (Africa CDC), Addis Ababa, Ethiopia.
¹⁵ Institute of Human Virology (IHV), University of Maryland School of Medicine, Baltimore, Maryland, United States of America.

Niteen Wairagkar et al. PLOS Glob Public Health. 2025.

. 2025 Feb 14;5(2):e0004276.

doi: 10.1371/journal.pgph.0004276. eCollection 2025.

¹ Vaccines for All, Pune, India.
² African Medicines Agency Secretariat, Kigali, Rwanda.
³ International Vaccine Institute, Kigali, Rwanda.
⁴ African Medicines Harmonization Initiative, AUDA NEPAD, South Africa.
⁵ Egyptian Drug Authority (EDA), Agouza, Giza, Egypt.
⁶ NAFDAC, Zone 7, Abuja, Nigeria.
⁷ Ghana Food and Drugs Authority, Accra, Ghana.
⁸ Food and Drugs Authority, Tanzania.
⁹ Medicines Control Authority of Zimbabwe, Harare, Zimbabwe.
¹⁰ South African Health Products Regulatory Authority, Pretoria, South Africa.
¹¹ Rwanda Food and Drugs Authority, Kigali, Rwanda.
¹² African Medicines Agency, Kigali, Rwanda.
¹³ College of Natural Sciences, Seoul National University, Seoul, South Korea.
¹⁴ Africa Centres for Disease Control and Prevention (Africa CDC), Addis Ababa, Ethiopia.
¹⁵ Institute of Human Virology (IHV), University of Maryland School of Medicine, Baltimore, Maryland, United States of America.

No abstract available

Conflict of interest statement

The authors have declared that no competing interests exist.

1. Ncube BM, Dube A, Ward K. The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies. Health Policy Plan. 2024;39(5):447–56. doi: 10.1093/heapol/czae017 - DOI - PMC - PubMed
1. Wairagkar N, Ismail AJ, Abouhussein DMN, Adeyeye MC, Darko DM, Fimbo AM, et al.. Regulatory reforms will boost African vaccine production and access. Nat Med. 2024;30(12):3409–12. doi: 10.1038/s41591-024-03314-x - DOI - PubMed
1. World Health Organization. WHO Global Benchmarking Tool (GBT) for evaluation of national regulatory systems of medicines and vaccines. [cited 2024 Nov 26]. Available from: https://www.who.int/tools/global-benchmarking-tools/VI
1. World Health Organization. Senegal and rwanda achieve ML-3 regulatory capacity. [cited 2025 Jan 6]. Available from: https://www.who.int/news/item/05-12-2024-senegal-and-rwanda-achieve-who-...
1. African Union Development Agency (AUDA-NEPAD). African Medicines Regulatory Harmonization initiative. [cited 2024 Nov 26]. Available from: https://amrh.nepad.org/amrh-microsite/who-we-are